Molecular characteristics of pediatric nasopharyngeal carcinoma using whole-exome sequencing

被引:0
作者
Wu, Bian [1 ]
Shen, Liangfang [2 ]
Peng, Gang [1 ]
Li, Yingqiang [3 ]
Zhou, Zhiyuan [1 ]
Li, Jingao [4 ]
Huang, Xiaodong [5 ]
Zhou, Qin [2 ]
Jiang, Hongguo [3 ]
Huang, Jing [1 ]
Ding, Qian [1 ]
Zhang, Zhanjie [1 ]
Qin, You [1 ]
Hong, Xiaohua [1 ]
Shi, Liangliang [1 ]
Zou, Zhenwei [1 ]
Yao, Jing [1 ]
Zhang, Jing [3 ]
Liu, Danni [3 ]
Wan, Chao [1 ]
Wu, Gang [1 ]
Song, Lele [3 ]
Chen, Shifu [3 ]
Yi, Junlin [5 ]
Yang, Kunyu [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan 430022, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Oncol, Changsha, Peoples R China
[3] HaploX Biotechnol, Shenzhen, Peoples R China
[4] Nanchang Univ, Dept Radiotherapy, Jiangxi Canc Hosp, Nanchang, Peoples R China
[5] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Radiat Oncol,Natl Clin Res Ctr Canc, Beijing, Peoples R China
关键词
Pediatric nasopharyngeal carcinoma; Rare cancer; Pediatric cancer; Whole exome sequencing; EPSTEIN-BARR-VIRUS; ANTITUMOR-ACTIVITY; CANCER; MUTATIONS; CHILDREN; RISK; LANDSCAPE; RECURRENT; ANTIBODY; FEATURES;
D O I
10.1016/j.oraloncology.2022.106218
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: While a number of genetic and epigenetic events contributing to adult nasopharyngeal carcinomas (aNPC) development has been established, the scarcity of pediatric nasopharyngeal carcinoma (pNPC) hinders the understanding of the biology of the disease and rational treatment approach. We aim to identify the mo-lecular characteristics of pNPC.Materials and Methods: pNPC primary tumors with paired blood samples were collected and sequenced using whole-exome sequencing. Samples were collected from four tertiary academic medical centers in China. A total of 30 patients (25 male and 5 female) with pathologically confirmed NPC under the age of 20 were enrolled.Results: Several genes such as C9orf84 (20 %), ZFHX4 (16.7 %), ZC3H6 (16.7 %), RBM38 (16.7 %) were frequently mutated in pNPC. Copy number analysis revealed highly recurring gain/amplification of the HLA class II genes at 6p21.32 (63.3 %) and losses of TOLLIP at 11p15.5 (20 %). Recurrent NUTM1 (16.7 %) fusion variants were found for the first time with pNPC. We also investigated germline genomic signatures and showed 8 of 30 (26.7 %) of the pNPC patients carrying germline pathogenic and/or likely pathogenic variants in known cancer -predisposing genes. Multi-dimensional comparison suggested that pNPC might exhibit distinct genomic profile compared to aNPC. In addition, pNPC exhibited significantly elevated level of PD-L1 expression than aNPC (percent of patients with >50 % PD-L1 expression: 92.0 % vs 32.1 %), suggesting high possibility of benefit from immunotherapy.Conclusion: Our results provide the first insight into the molecular basis of pNPC, and might offer novel targets and therapeutic approaches such as immunotherapy for this rare disease.
引用
收藏
页数:8
相关论文
共 41 条
  • [1] Signatures of mutational processes in human cancer
    Alexandrov, Ludmil B.
    Nik-Zainal, Serena
    Wedge, David C.
    Aparicio, Samuel A. J. R.
    Behjati, Sam
    Biankin, Andrew V.
    Bignell, Graham R.
    Bolli, Niccolo
    Borg, Ake
    Borresen-Dale, Anne-Lise
    Boyault, Sandrine
    Burkhardt, Birgit
    Butler, Adam P.
    Caldas, Carlos
    Davies, Helen R.
    Desmedt, Christine
    Eils, Roland
    Eyfjord, Jorunn Erla
    Foekens, John A.
    Greaves, Mel
    Hosoda, Fumie
    Hutter, Barbara
    Ilicic, Tomislav
    Imbeaud, Sandrine
    Imielinsk, Marcin
    Jaeger, Natalie
    Jones, David T. W.
    Jones, David
    Knappskog, Stian
    Kool, Marcel
    Lakhani, Sunil R.
    Lopez-Otin, Carlos
    Martin, Sancha
    Munshi, Nikhil C.
    Nakamura, Hiromi
    Northcott, Paul A.
    Pajic, Marina
    Papaemmanuil, Elli
    Paradiso, Angelo
    Pearson, John V.
    Puente, Xose S.
    Raine, Keiran
    Ramakrishna, Manasa
    Richardson, Andrea L.
    Richter, Julia
    Rosenstiel, Philip
    Schlesner, Matthias
    Schumacher, Ton N.
    Span, Paul N.
    Teague, Jon W.
    [J]. NATURE, 2013, 500 (7463) : 415 - +
  • [2] Childhood nasopharyngeal carcinoma: from biology to treatment
    Ayan, I
    Kaytan, E
    Ayan, N
    [J]. LANCET ONCOLOGY, 2003, 4 (01) : 13 - 21
  • [3] DNA mismatch repair in cancer
    Baretti, Marina
    Le, Dung T.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2018, 189 : 45 - 62
  • [4] Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma
    Bauer, Daniel E.
    Mitchell, Chelsey M.
    Strait, Kelly M.
    Lathan, Christopher S.
    Stelow, Edward B.
    Lueer, Sonja C.
    Muhammed, Somala
    Evans, Andrew G.
    Sholl, Lynette M.
    Rosai, Juan
    Giraldi, Eugenia
    Oakley, Richard P.
    Rodriguez-Galindo, Carlos
    London, Wendy B.
    Sallan, Stephen E.
    Bradner, James E.
    French, Christopher A.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (20) : 5773 - 5779
  • [5] Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults
    Buehrlen, Martina
    Zwaan, Christian Michel
    Granzen, Bernd
    Lassay, Lisa
    Deutz, Peter
    Vorwerk, Peter
    Staatz, Gundula
    Gademann, Guenther
    Christiansen, Hans
    Oldenburger, Foppe
    Tamm, Miriam
    Mertens, Rolf
    [J]. CANCER, 2012, 118 (19) : 4892 - 4900
  • [6] Update in pediatric nasopharyngeal undifferentiated carcinoma
    Claude, Line
    Jouglar, Emmanuel
    Duverge, Loig
    Orbach, Daniel
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2019, 92 (1102)
  • [7] A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32
    Cozen, Wendy
    Li, Dalin
    Best, Timothy
    Van den Berg, David J.
    Gourraud, Pierre-Antoine
    Cortessis, Victoria K.
    Skol, Andrew D.
    Mack, Thomas M.
    Glaser, Sally L.
    Weiss, Lawrence M.
    Nathwani, Bharat N.
    Bhatia, Smita
    Schumacher, Fredrick R.
    Edlund, Christopher K.
    Hwang, Amie E.
    Slager, Susan L.
    Fredericksen, Zachary S.
    Strong, Louise C.
    Habermann, Thomas M.
    Link, Brian K.
    Cerhan, James R.
    Robison, Leslie L.
    Conti, David V.
    Onel, Kenan
    [J]. BLOOD, 2012, 119 (02) : 469 - 475
  • [8] NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors
    Dickson, Brendan C.
    Sung, Yun-Shao
    Rosenblum, Marc K.
    Reuter, Victor E.
    Harb, Mohammed
    Wunder, Jay S.
    Swanson, David
    Antonescu, Cristina R.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2018, 42 (05) : 636 - 645
  • [9] Childhood Nasopharyngeal Carcinoma: State-of-the-Art, and Questions for the Future
    Dourthe, Marie-Emilie
    Bolle, Stephanie
    Temam, Stephane
    Jouin, Anais
    Claude, Line
    Reguerre, Yves
    Defachelles, Anne-Sophie
    Orbach, Daniel
    Fresneau, Brice
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (02) : 85 - 92
  • [10] Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
    Fang, Wenfeng
    Yang, Yunpeng
    Ma, Yuxiang
    Hong, Shaodong
    Lin, Lizhu
    He, Xiaohui
    Xiong, Jianping
    Li, Ping
    Zhao, Hongyun
    Huang, Yan
    Zhang, Yang
    Chen, Likun
    Zhou, Ningning
    Zhao, Yuanyuan
    Hou, Xue
    Yang, Qing
    Zhang, Li
    [J]. LANCET ONCOLOGY, 2018, 19 (10) : 1338 - 1350